Laurie Gutmann
Neuroscience · Indiana University
Publications
174
Citations
6,692
Est. group size
—
Recurring co-author estimate
Active years
50
Publishing since 1977
Laurie Gutmann studies inherited and progressive disorders of nerves and muscles, including myotonic dystrophy type 1 and Charcot-Marie-Tooth disease. The work focuses on tracking disease progression over time and developing measurable markers—such as MRI imaging, blood proteins, and genetic findings—to detect and monitor these conditions. A separate strand examines professional and educational issues within academic neurology.
Publication activity peaked around 2020–2021 and has since slowed, averaging under three papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- The Interplay of Parental Leave, Career Achievement, and Burnout in Academic Neurologists: A Multicenter Study
Journal of Women s Health · 2026
- The Auxiliary to the American Academy of Neurology
Neurology · 2024
- Longitudinal changes in white matter as measured with diffusion tensor imaging in adult-onset myotonic dystrophy type 1
Neuromuscular Disorders · 2023
- Disease Progression in Charcot–Marie–Tooth Disease Related to <scp><i>MPZ</i></scp> Mutations: A Longitudinal Study
Annals of Neurology · 2022
- Blood-Based Markers of Neuronal Injury in Adult-Onset Myotonic Dystrophy Type 1
Frontiers in Neurology · 2022
- Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1
Frontiers in Neurology · 2021
- MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1A
Neurology · 2021
- Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1
Muscle & Nerve · 2021
- Funding the Educational Mission in Neurology
Neurology · 2021
- White matter microstructure relates to motor outcomes in myotonic dystrophy type 1 independently of disease duration and genetic burden
Scientific Reports · 2021
- Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
Neurology Genetics · 2021
- Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices
Neurology Genetics · 2021
- Results of Double-blind, Placebo-controlled, Dose Range Finding, Crossover Study of Single Day Administration of ERX-963 (IV Flumazenil) in Adults with Myotonic Dystrophy Type 1 (2834)
Neurology · 2021
- Author response: Subspecialization in clinical neurophysiology: Development and current status
2021
- Additional file of Skeletal muscle gene expression in response to resistance exercise: sex specific regulation
Open MIND · 2021
- Neurology×25
- Muscle & Nerve×6
- Neurology Genetics×3
- Neurology Clinical Practice×2
- Annals of Neurology×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile